Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap Methodology Development Environmental Trial in Seasonal Allergic Conjunctivitis
NCT03660878Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Sep 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in seasonal allergic conjunctivitis (SAC), sponsored by Aldeyra Therapeutics. Started Sep 2018; status: completed.
02
Drugs
reproxalap
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT03660878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660878.